JYB-1931

N/A

Report date: 2025/02/26 13:21:43

Base Information

Drug NameJYB-1931
Drug Alias NameJYB-1931JYB1931
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionMannan-binding lectin serine protease 2 inhibitors
TargetsMannan-binding lectin serine protease 2
Therapy Area/IndicationsGlomerulonephritis, IGAKidney Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangxi Jemincare Group Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesJiangsu Jiye Biopharmaceutical Co LtdShanghai Jiyu Pharmaceutical Technology Co LtdJiangxi Jemincare Group Co Ltd
Inactive CompaniesN/A
Active IndicationsGlomerulonephritis, IGAKidney Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A